Neurokinin-1 receptor agonists bias therapeutic dendritic cells to induce type 1 immunity by licensing host dendritic cells to produce IL-12

Authors:

Abstract
Key Points: Therapeutic DCs stimulated via NK1R stimulate type 1–biased immunity.

This publication has 50 references indexed in Scilit: